Log in
OTCMKTS:IPCIF

Intellipharmaceutics International SEC Filings & 10K Form

$0.19
-0.01 (-7.27 %)
(As of 10/21/2020 12:48 PM ET)
Add
Compare
Today's Range
$0.19
Now: $0.19
$0.21
50-Day Range
$0.09
MA: $0.13
$0.22
52-Week Range
$0.06
Now: $0.19
$0.95
Volume27,205 shs
Average Volume105,774 shs
Market Capitalization$4.50 million
P/E RatioN/A
Dividend YieldN/A
Beta1.76

SEC Filings

Intellipharmaceutics International (OTCMKTS:IPCIF) SEC Filings

DateFilerForm TypeView
10/15/2020
4:26 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2020
4:29 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2020
10:09 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2020
4:28 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2020
5:58 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2020
4:29 PM
Intellipharmaceutics International (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/11/2020
6:00 AM
Intellipharmaceutics International (Subject)
UBS Group AG (Filed by)
Form SC 13G/A
02/05/2020
4:04 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2020
12:53 PM
Intellipharmaceutics International (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
01/16/2020
7:09 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2019
8:36 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2019
3:39 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2019
3:38 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2019
3:20 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2019
12:48 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2019
4:20 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2019
7:07 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2019
12:44 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2019
2:28 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/24/2019
4:13 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2019
4:08 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/08/2019
4:18 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2019
8:59 AM
Intellipharmaceutics International (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
05/30/2019
7:51 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2019
4:07 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2019
2:18 PM
Intellipharmaceutics International (Filer)
Form 424B3
05/29/2019
2:13 PM
Intellipharmaceutics International (Filer)
Form 424B3
05/29/2019
8:38 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2019
3:41 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2019
2:26 PM
Intellipharmaceutics International (Filer)
Form 424B3
05/10/2019
2:18 PM
Intellipharmaceutics International (Filer)
Form 424B3
05/10/2019
12:07 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2019
11:13 AM
Intellipharmaceutics International (Filer)
Form 424B3
04/26/2019
11:10 AM
Intellipharmaceutics International (Filer)
Form 424B3
04/17/2019
9:49 AM
Intellipharmaceutics International (Filer)
Form 424B3
04/17/2019
9:46 AM
Intellipharmaceutics International (Filer)
Form 424B3
04/15/2019
3:25 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/29/2019
7:57 AM
Intellipharmaceutics International (Filer)
Form 424B3
03/29/2019
7:55 AM
Intellipharmaceutics International (Filer)
Form 424B3
03/29/2019
7:53 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2019
6:50 AM
Intellipharmaceutics International (Filer)
Form 424B3
03/20/2019
6:46 AM
Intellipharmaceutics International (Filer)
Form 424B3
03/04/2019
7:34 AM
Intellipharmaceutics International (Filer)
Form 424B3
03/04/2019
7:04 AM
Intellipharmaceutics International (Filer)
Form 424B3
03/04/2019
6:40 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2019
6:13 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2019
6:05 AM
Intellipharmaceutics International (Filer)
Form 20-F/A
02/28/2019
8:45 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2019
4:25 PM
Intellipharmaceutics International (Filer)
Form 424B3
02/26/2019
4:21 PM
Intellipharmaceutics International (Filer)
Form 424B3
02/22/2019
4:24 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2019
7:12 AM
Intellipharmaceutics International (Filer)
Form 424B3
02/20/2019
7:10 AM
Intellipharmaceutics International (Filer)
Form 424B3
02/20/2019
7:06 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2019
1:31 PM
ARMISTICE CAPITAL, LLC (Filed by)
Intellipharmaceutics International (Subject)
Form SC 13G/A
02/14/2019
12:44 PM
Anson Funds Management LP (Filed by)
Intellipharmaceutics International (Subject)
Form SC 13G/A
02/04/2019
4:49 PM
Intellipharmaceutics International (Filer)
Form 424B3
02/04/2019
4:49 PM
Intellipharmaceutics International (Filer)
Form 424B3
02/04/2019
4:10 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2019
2:48 PM
Empery Asset Management, LP (Filed by)
Intellipharmaceutics International (Subject)
Form SC 13G/A
01/29/2019
2:40 PM
Intellipharmaceutics International (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
01/29/2019
2:30 PM
Intellipharmaceutics International (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
01/28/2019
4:14 PM
Intellipharmaceutics International (Filer)
Form 424B3
01/28/2019
4:11 PM
Intellipharmaceutics International (Filer)
Form 424B3
01/28/2019
4:06 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/07/2019
7:17 AM
Intellipharmaceutics International (Filer)
Form 424B3
01/07/2019
7:14 AM
Intellipharmaceutics International (Filer)
Form 424B3
01/07/2019
7:09 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/06/2018
10:17 AM
Intellipharmaceutics International (Filer)
Form 424B3
12/06/2018
10:12 AM
Intellipharmaceutics International (Filer)
Form 424B3
12/04/2018
8:53 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/30/2018
4:27 PM
Empery Asset Management, LP (Filed by)
Intellipharmaceutics International (Subject)
Form SC 13G
11/28/2018
1:42 PM
Intellipharmaceutics International (Filer)
Form 424B3
11/28/2018
1:39 PM
Intellipharmaceutics International (Filer)
Form 424B3
11/27/2018
4:14 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/27/2018
2:36 PM
Intellipharmaceutics International (Filer)
Form 424B3
11/27/2018
2:22 PM
Intellipharmaceutics International (Filer)
Form 424B3
11/27/2018
2:18 PM
Intellipharmaceutics International (Filer)
Form 424B3
11/27/2018
2:15 PM
Intellipharmaceutics International (Filer)
Form 424B3
11/27/2018
7:10 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2018
8:37 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2018
4:24 PM
Intellipharmaceutics International (Filer)
Form 424B3
11/21/2018
4:22 PM
Intellipharmaceutics International (Filer)
Form 424B3
11/21/2018
3:30 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2018
10:56 AM
Intellipharmaceutics International (Filer)
Form 424B3
11/21/2018
10:53 AM
Intellipharmaceutics International (Filer)
Form 424B3
11/05/2018
8:27 PM
Intellipharmaceutics International (Filer)
Form 424B3
11/05/2018
8:22 PM
Intellipharmaceutics International (Filer)
Form 424B3
10/26/2018
3:28 PM
Intellipharmaceutics International (Filer)
Form 424B3
10/26/2018
3:17 PM
Intellipharmaceutics International (Filer)
Form 424B3
10/26/2018
3:14 PM
Intellipharmaceutics International (Subject)
ODIDI HOLDINGS INC. (Filed by)
Form SC 13D/A
10/26/2018
7:06 AM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2018
1:06 PM
Intellipharmaceutics International (Filer)
Form 424B3
10/23/2018
1:02 PM
Intellipharmaceutics International (Filer)
Form 424B3
10/18/2018
4:19 PM
ARMISTICE CAPITAL, LLC (Filed by)
Intellipharmaceutics International (Subject)
Form SC 13G/A
10/17/2018
1:49 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2018
8:16 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2018
4:29 PM
Intellipharmaceutics International (Filer)
Form 424B3
10/16/2018
4:27 PM
Intellipharmaceutics International (Filer)
Form 424B3
10/15/2018
4:25 PM
Intellipharmaceutics International (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.